+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Telemonitoring Systems - Global Strategic Business Report

  • PDF Icon

    Report

  • 186 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140536
The global market for Telemonitoring Systems was valued at USD 2.7 Billion in 2024 and is projected to reach USD 4.5 Billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Telemonitoring Systems Market - Key Trends and Drivers Summarized

What Are Telemonitoring Systems and Why Are They Critical in Healthcare?

Telemonitoring systems enable healthcare providers to remotely monitor patients' vital signs, symptoms, and overall health conditions using digital communication technologies. These systems are essential for chronic disease management, post-acute care, and elderly care, providing continuous monitoring without the need for frequent hospital visits. By transmitting real-time data such as blood pressure, heart rate, glucose levels, and oxygen saturation, telemonitoring systems allow healthcare professionals to make timely interventions, adjust treatment plans, and improve patient outcomes. This is particularly vital in the context of an aging population and increasing incidences of chronic diseases such as diabetes and cardiovascular conditions, where proactive monitoring is key to reducing hospitalizations and managing healthcare costs.

How Are Telemonitoring Systems Being Used Across Healthcare Settings?

Telemonitoring systems are widely used in hospitals, clinics, and home healthcare settings, providing flexibility for both patients and providers. In hospital settings, telemonitoring is integrated into broader telehealth strategies, allowing clinicians to track the recovery of patients post-surgery or during treatment for chronic conditions. In home healthcare, telemonitoring empowers patients to self-manage their health, while doctors and nurses can access patient data remotely to make informed decisions. This is particularly beneficial in rural areas where access to healthcare facilities is limited. Additionally, telemonitoring systems are employed in specialized care, such as remote monitoring for patients undergoing rehabilitation, as well as for maternity and pediatric care to ensure continuous oversight without frequent hospital visits.

What Are the Key Segments in the Telemonitoring Systems Market?

Key components include devices (such as sensors, wearables, and mobile health apps) and services (such as data collection, analytics, and real-time reporting). Applications span chronic disease management, post-acute care, preventive care, and elderly care. In terms of end-use, hospitals, home care settings, and clinics form the primary market segments. Regionally, North America leads the market due to advanced healthcare infrastructure, while Asia-Pacific is witnessing rapid growth driven by increasing adoption of telehealth technologies and government initiatives to improve healthcare access in remote areas. Emerging markets are also contributing to growth as healthcare providers embrace telemonitoring to address infrastructure challenges.

The Growth in the Telemonitoring Systems Market Is Driven by Several Factors

The growth in the telemonitoring systems market is driven by several factors, including the rising prevalence of chronic diseases, the growing elderly population, and advancements in wearable and wireless technologies. The increasing focus on home healthcare solutions, which allow patients to manage their conditions from home, is significantly boosting the demand for telemonitoring systems. Additionally, regulatory support for telehealth and reimbursement policies in regions like North America and Europe are fueling market expansion. The integration of AI and machine learning into telemonitoring systems is further enhancing predictive analytics capabilities, enabling more proactive care. The rapid adoption of 5G technology, which facilitates real-time data transmission with minimal latency, is also expected to accelerate market growth.

Report Scope

The report analyzes the Telemonitoring Systems market, presented in terms of market value (USD Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments

End-Use (COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring, Other End-Uses).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the COPD Monitoring End-Use segment, which is expected to reach $1.2 Billion by 2030 with a CAGR of a 8.1%. The Blood Pressure Monitoring End-Use segment is also set to grow at 9.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $705.3 Million in 2024, and China, forecasted to grow at an impressive 11.4% CAGR to reach $986.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in USD from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Aerotel Medical Systems (19) Ltd., Allscripts Healthcare Solutions, Inc., BioTelemetry, Inc., Biotronik SE & Co. KG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Telemonitoring Systems Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Telemonitoring Systems Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Telemonitoring Systems Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 26 major companies featured in this Telemonitoring Systems market report include:

  • Abbott Laboratories
  • Aerotel Medical Systems (19) Ltd.
  • Allscripts Healthcare Solutions, Inc.
  • BioTelemetry, Inc.
  • Biotronik SE & Co. KG
  • Dragerwerk AG & Co. KGaA
  • Dream Systems LLC.
  • eVisit, Inc.
  • General Electric Company
  • Honeywell Life Care Solutions
  • Huawei Technologies Co., Ltd.
  • InTouch Health
  • LifeWatch AG
  • McKesson Corporation
  • Medtronic, Inc.
  • Philips Healthcare USA

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Telemonitoring Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Chronic Diseases Drives Adoption of Telemonitoring Systems
  • Rising Demand for Remote Patient Monitoring Strengthens Business Case for Telemonitoring
  • Growth of the Elderly Population Spurs Demand for Telemonitoring Solutions
  • Advancements in Wireless and Wearable Technologies Propel Growth in Telemonitoring
  • Expanding Use of Telemonitoring in Post-Acute Care Accelerates Market Expansion
  • Rising Healthcare Costs Drive Adoption of Cost-Effective Remote Monitoring Systems
  • Integration of AI and Machine Learning in Telemonitoring Systems Enhances Market Growth
  • Increased Focus on Home Healthcare Solutions Spurs Demand for Telemonitoring
  • Growing Use of Telemonitoring for Managing Diabetes and Cardiovascular Diseases Propels Market
  • Shift Toward Value-Based Care Strengthens Demand for Remote Monitoring Solutions
  • Emergence of 5G Technology Accelerates Adoption of Real-Time Telemonitoring
  • COVID-19 Pandemic Throws the Spotlight on Remote Monitoring and Telehealth Solutions
  • Rising Demand for Real-Time Data Analytics and Predictive Insights in Healthcare Sustains Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Telemonitoring Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 3: World Historic Review for Telemonitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 4: World 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for COPD Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 6: World Historic Review for COPD Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 7: World 15-Year Perspective for COPD Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Blood Pressure Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 9: World Historic Review for Blood Pressure Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 10: World 15-Year Perspective for Blood Pressure Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Glucose Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 12: World Historic Review for Glucose Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 13: World 15-Year Perspective for Glucose Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 15: World Historic Review for Cardiovascular Disease Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 16: World 15-Year Perspective for Cardiovascular Disease Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 21: USA Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 22: USA 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 24: Canada Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 25: Canada 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 26: Japan Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 27: Japan Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 28: Japan 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 29: China Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 30: China Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 31: China 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 32: Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Telemonitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 34: Europe 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 35: Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 36: Europe Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 37: Europe 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 38: France Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 39: France Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 40: France 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 41: Germany Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 42: Germany Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 43: Germany 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
  • Table 44: Italy Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 45: Italy Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 46: Italy 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 47: UK Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 48: UK Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 49: UK 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
  • Table 50: Spain Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 51: Spain Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 52: Spain 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
  • Table 53: Russia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 54: Russia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 55: Russia 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 56: Rest of Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 57: Rest of Europe Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 58: Rest of Europe 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 60: Asia-Pacific Historic Review for Telemonitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 61: Asia-Pacific 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • Table 62: Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 63: Asia-Pacific Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 64: Asia-Pacific 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Aerotel Medical Systems (19) Ltd.
  • Allscripts Healthcare Solutions, Inc.
  • BioTelemetry, Inc.
  • Biotronik SE & Co. KG
  • Dragerwerk AG & Co. KGaA
  • Dream Systems LLC.
  • eVisit, Inc.
  • General Electric Company
  • Honeywell Life Care Solutions
  • Huawei Technologies Co., Ltd.
  • InTouch Health
  • LifeWatch AG
  • McKesson Corporation
  • Medtronic, Inc.
  • Philips Healthcare USA

Table Information